{"slug":"tirzepatide-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"718cad54b51616d340a52a2a054088ce3ca6d05c7b0891daee01912288a11387"},"energy":{"passes":2,"tokens_in":30524,"tokens_out":3345,"tokens_total":33869,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"718cad54b51616d340a52a2a054088ce3ca6d05c7b0891daee01912288a11387"},"provenance":[{"ts":"2026-06-29T22:50:01.280Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Diabetic Neuropathy\nSlug: tirzepatide-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"tirzepatide\",\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n3. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on ","response":"{\n  \"slug\": \"tirzepatide-diabetic-neuropathy\",\n  \"title\": \"Tirzepatide for Diabetic Neuropathy: Evidence on Metabolic Pathways\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive damage to peripheral nerves driven by sustained high blood glucose. This creates oxidative stress, inflammation, and impaired blood flow to nerve fibers. Small nerve fibers often degenerate first, leading to sensory changes, pain, or loss of sensation. Over time, larger fibers can be affected, impacting balance and muscle function. The core issue is a mismatch where degenerative processes from hyperglycemia outpace the body's repair capacity in nerve tissue. Metabolic factors like excess body weight add systemic load that can worsen glycemic control and inflammation. Repair requires addressing the underlying drivers rather than only suppressing symptoms.\\n\\n## Why Tirzepatide might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Same metabolic overload pattern as other GLP-1 contexts at higher body weight, with hyperglycemia damaging nerves over time.\\n3. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP effects on weight loss and glycemic control — this can reduce overall metabolic stress on nerves and tissues.\\n4. **Therefore for you:** If metabolic load or poor glucose control is part of your problem, Tirzepatide is discussed because it targets repair through these pathways — not because it masks pain.\\n\\nTirzepatide activates GLP-1 and GIP receptors. This leads to reduced appetite, lower calorie intake, and substantial weight reduction in human studies. Weight loss of even 10-15% can improve insulin sensitivity and lower average blood glucose. Better glycemic control directly limits further nerve damage from high sugar. In addition, the associated drop in body weight reduces chronic low-grade inflammation that contributes t","tokens_in":30524,"tokens_out":3345,"cost":0,"prev":"genesis","hash":"118108bba71758f4d35980783c546aac9a47cedd2155d4417e0ecd81be50e076"},{"ts":"2026-07-17T02:43:15.294Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-diabetic-neuropathy","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"118108bba71758f4d35980783c546aac9a47cedd2155d4417e0ecd81be50e076","hash":"718cad54b51616d340a52a2a054088ce3ca6d05c7b0891daee01912288a11387"}]}